| |
| |
|
| Insider
Information: |
Scangos George A |
| Relationship: |
Director |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
942,251 |
|
|
Indirect Shares
|
3,765,803 |
|
|
| Direct
Value |
$30,457,340 |
|
|
|
Indirect Value
|
$5,320,395 |
|
|
| Total
Shares |
4,708,054 |
|
|
| Total
Value |
$35,777,735 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Exelixis Inc |
EXEL |
Director |
2020-05-18 |
714,717 |
2020-05-18 |
23,595 |
Premium* |
|
|
Anadys Pharmaceuticals Inc |
ANDS |
Director |
2008-08-26 |
33,188 |
2004-03-31 |
0 |
Premium* |
|
|
Biogen Idec Inc |
BIIB |
Chief Executive Office... |
2016-07-21 |
54,779 |
2016-07-21 |
10,756 |
Premium* |
|
|
Agilent Technologies Inc |
A |
Director |
2024-05-29 |
18,578 |
2024-05-29 |
17,893 |
Premium* |
|
|
Vir Biotechnology, Inc. |
VIR |
Director |
2024-05-30 |
120,989 |
2024-05-30 |
3,713,559 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
379 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 12 of 16
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2016-02-09 |
4 |
D |
$249.99 |
$1,326,197 |
D/D |
(5,305) |
47,059 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2020-04-21 |
4 |
AS |
$25.04 |
$145,232 |
D/D |
(5,800) |
857,231 |
0 |
% |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2016-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
6,383 |
1,310,210 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2018-11-29 |
4 |
AS |
$20.00 |
$130,000 |
D/D |
(6,500) |
1,505,481 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2012-02-10 |
4 |
D |
$118.14 |
$827,807 |
D/D |
(7,007) |
66,283 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2020-04-08 |
4 |
AS |
$18.35 |
$129,643 |
D/D |
(7,065) |
938,031 |
0 |
% |
|
| VIR |
Vir Biotechnology, Inc. |
Director |
– • – |
2024-05-30 |
4 |
A |
$0.00 |
$0 |
D/D |
8,000 |
120,989 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2018-11-30 |
4 |
AS |
$20.00 |
$170,000 |
D/D |
(8,500) |
1,496,981 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2011-07-14 |
4 |
D |
$104.00 |
$914,264 |
D/D |
(8,791) |
54,374 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2015-02-10 |
4 |
D |
$395.13 |
$3,505,198 |
D/D |
(8,871) |
34,277 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2014-02-10 |
4 |
D |
$315.54 |
$2,801,995 |
D/D |
(8,880) |
55,417 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2013-02-10 |
4 |
D |
$164.44 |
$1,461,872 |
D/D |
(8,890) |
56,901 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2011-07-15 |
4 |
D |
$104.00 |
$926,744 |
D/D |
(8,911) |
66,804 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2014-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,189 |
62,150 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2015-02-12 |
4/A |
OE |
$0.00 |
$0 |
D/D |
9,189 |
43,466 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2013-02-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,767 |
50,681 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
President and CEO |
• • – |
2023-02-17 |
4 |
AS |
$25.29 |
$250,199 |
D/D |
(9,894) |
214,095 |
0 |
- |
|
| ANDS |
Anadys Pharmaceuticals In... |
Director |
– • – |
2008-08-26 |
4 |
B |
$2.70 |
$27,000 |
D/D |
10,000 |
33,188 |
2.39 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
President and CEO |
• • – |
2022-02-17 |
4 |
AS |
$31.93 |
$320,074 |
D/D |
(10,024) |
130,715 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
Director |
– • – |
2024-02-22 |
4 |
AS |
$10.05 |
$100,737 |
D/D |
(10,028) |
130,711 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2014-07-15 |
4 |
D |
$312.00 |
$3,139,344 |
D/D |
(10,062) |
34,812 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2015-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
10,149 |
52,681 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2012-11-29 |
4 |
GD |
$0.00 |
$0 |
D/D |
10,756 |
40,914 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2012-11-29 |
4 |
GA |
$0.00 |
$0 |
I/I |
10,756 |
5,378 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
Director |
– • – |
2024-02-16 |
4 |
AS |
$10.24 |
$111,386 |
D/D |
(10,878) |
157,611 |
0 |
- |
|
379 Records found
|
|
Page 12 of 16 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
